MCM-test: a fuzzy-set-theory-based approach to differential analysis of gene pathways

Lily R Liang1, Vinay Mandal, Yi Lu

  • 1Department of Computer Science and Information Technology, University of the District of Columbia, Washington, DC, USA. lliang@udc.edu

BMC Bioinformatics
|June 27, 2008
PubMed
Abstract

Insights

This study introduces the Multi-dimensional Cluster Misclassification test (MCM-test) to assess gene pathway significance in diseases. The MCM-test identified mitochondrial pathways as deregulated in diabetes, supporting their role in insulin resistance.

Area of Science:

  • Genomics
  • Systems Biology
  • Bioinformatics

Background:

  • Gene pathways, groups of interacting genes, are increasingly recognized for their roles in disease pathogenesis.
  • Understanding gene pathway involvement is crucial for disease research beyond individual gene identification.

Purpose of the Study:

  • To propose and validate an innovative fuzzy-set-theory-based approach, the Multi-dimensional Cluster Misclassification test (MCM-test).
  • To measure the significance of gene pathways in the context of specific diseases.

Main Methods:

  • Development of the Multi-dimensional Cluster Misclassification test (MCM-test) using fuzzy-set theory.
  • Application of MCM-test to both synthetic and real-world gene expression datasets.
  • Utilized KEGG pathways for analysis of a published diabetes gene expression dataset.

Main Results:

  • The MCM-test successfully identified deregulated pathways in diabetes.
  • Specifically, the OXPHOS pathway and other mitochondrial pathways were found to be deregulated in diabetes patients.
  • Results align with existing evidence linking mitochondrial dysfunction to insulin resistance and type-2 diabetes.

Conclusions:

  • The MCM-test is a viable tool for pathway-level differential analysis of gene expression data.
  • This method offers a novel solution for comparing two groups of data, a fundamental task across research disciplines.